Advanced Therapies Integrates North 2025

Bringing together industry leaders to drive the full potential of Advanced Therapies

30th April 2025

EVENT TOPICS:

  • A Digital Revolution & A Person-Centric Approach

Advanced Therapies Integrates North is dedicated to uniting industry leaders to drive and realize the full potential of Advanced Therapies and Medicinal Products (ATMPs). The event will focus on the key innovations within complex therapeutics, cell and gene therapies, regenerative medicines and tissue therapies and identify the challenges facing the industry, such as regulatory and commercial barriers to deploying transformational changes.

Uniquely engaging the broadest possible network, including innovators, regulators, supply chain partners, equipment and technology providers, academia, industry associations, and a wide array of government funding bodies and ATMP-focused initiatives, Advanced Therapies Integrates aims to become the leading UK event for translating cutting-edge research and disruptive innovation into widespread adoption of Advanced Therapies, delivering improved patient outcomes and revolutionizing healthcare economics.

HEADLINE SPONSOR:

SPONSORS AND PARTNERS INCLUDE:

Cell and Gene Therapy Catapult Labman AscellaHealth Miltenyi Biotec Alto Marketing

KEY SPEAKERS INCLUDE:

Register Now
Jacqueline Barry

Jacqueline Barry

Cell and Gene Therapy Catapult
Chief Clinical Officer
Adam Inche

Adam Inche

Lentitek
Founder
Terri Gaskell

Terri Gaskell

Rinri Therapeutics Ltd
Chief Technical Officer
Nicole Mather

Nicole Mather

IBM & Cell and Gene Therapy Catapult
Health Data, AI and Life Sciences Lead & Non Executive Director
Lara Campana

Lara Campana

Resolution Therapeutics
SVP Head of Research and Translational Science
Bryan Kobel

Bryan Kobel

TC BioPharm
Chief Executive Officer

AGENDA:

08:45 - 09:45
Registration and Networking
09:45 - 09:55
Opening Remarks
CGT Catapult
Jacqueline Barry
Facilitated by

Jacqueline Barry

Cell and Gene Therapy Catapult
Chief Clinical Officer

10:00 - 10:20
Fireside Chat

A Digital Revolution & A Person-Centric Approach

10:25 - 11:05

Digitally Driven

Digital technologies are reshaping the ATMP R&D landscape, driving faster, smarter and more efficient development pathways. This session will explore how emerging innovations are being harnessed in the UK to overcome process development, QC and manufacturing bottlenecks

Facilitated by

Nicole Mather

IBM & Cell and Gene Therapy Catapult
Health Data, AI and Life Sciences Lead & Non Executive Director

PANELLISTS

  • Antoine Espinet | MicrofluidX
  • Gloria Lam | PA Consulting
  • Daniel Gibson | Cell and Gene Therapy Catapult
  • Lindsay Fraser | Cytomos
  • Tom Smith | Labman Automation

11:05 - 11:35

Networking Coffee Break

11:35 - 12:15

Trial Blazers

The UK boasts world-class clinical development infrastructure, but is it keeping pace with global competition in ATMPs? With insights from leading UK CROs and a review of the NIHR Advanced Therapy Treatment Centre (ATTC) funding one year on, we’ll explore key learnings and outline what’s next for advancing ATMP clinical development in the UK.

Facilitated by

Jacqueline Barry

Cell and Gene Therapy Catapult
Chief Clinical Officer

PANELLISTS

  • Lara Campana | Resolution Therapeutics
  • Brian Bigger | University of Edinburgh
  • Gary White | IQVIA

12:20 - 13:00

Strength in Numbers

No one succeeds alone in the world of advanced therapies. This panel will explore the power of collaboration in ATMP development and discuss practical tips for forging partnerships that work.

Facilitated by

Ian Parnham

PANELLISTS

  • Josiane Chuisseu | Cellular Highways
  • Adam Inche | Lentitek
  • Remy Martin | eXmoor Pharma
  • Bryan Kobel | TC BioPharm
  • Gillian Molloy | AscellaHealth

13:00 - 14:00

Networking Lunch Break

14:00 - 14:40

The Price is Right?

How can we balance commercial viability of ATMPs with patient accessibility and affordability? This panel will examine the UK’s ATMP funding and reimbursement structure, exploring VPAG, funding hurdles, and how the UK can remain competitive on a global scale. 

PANELLISTS

  • James Kusena | MFX
  • Terri Gaskell | Rinri Therapeutics Ltd
  • Panos Kefalas | Cell and Gene Therapy Catapult
  • Alan Griffith | VectorBuilder
  • Julie Jacko | College of Medicine & Veterinary Medicine & Usher Institute

14:45 - 15:25

Putting Patients First

How can we ensure that advanced therapies are designed with the patient in mind? Are we doing enough to capture the patient voice during clinical trials? This panel will discuss the value of placing patients at the heart of therapeutic development. 

Facilitated by

Anna Couturier

The University of Edinburgh
Head of Research, Development, and Strategy, EuroGCT | EuroStemCell

PANELLISTS

  • Tia Papoutselou | Rinri Therapeutics
  • Arunesh Sil | Sanofi
  • Caoimhe Nic An tSaoir | Lonrú Consulting
  • Paula Shutt | Sickle Cell Society
  • Priscilla Fernandez | The University of Edinburgh

15:25 - 16:25

Networking Drinks Reception

VENUE:

The Usher Institute, Edinburgh

The Usher Institute, Edinburgh

Advanced Therapies Integrates 2025 Venue: The Usher Institute


The Usher Institute


The Usher Institute is a key applied and translational arm of the Edinburgh Medical School, within the College of Medicine and Veterinary Medicine at the University of Edinburgh; offering significant expertise in health services research, health informatics, data science and social science.

We strive for and work towards the data-enabled transformation of health.

The Usher Building


The Usher Building at Edinburgh BioQuarter will host partnerships for data-driven health solutions.

It is a welcoming space for focus, collaboration and engagement.

The Usher Building provides space and opportunities for academics and partners to work and collaborate in new and innovative ways towards our shared purpose of developing data-enabled solutions to benefit health and wellbeing. It is home to our on-campus Master of Public Health programme – with our students bringing enthusiasm and new perspectives each year – as well as being the base for our online postgraduate taught programmes.

Its location is a core part of Edinburgh’s Health Innovation District at BioQuarter and helps to develop links to the local community.

Getting here

The Usher Institute is based at the Usher Building at Edinburgh BioQuarter.

Directions for arriving at our site by car, foot or public transport can be found below.

Travel and nearby park & ride information.

Address:

The Usher Building, The University of Edinburgh, 5-7 Little France Road, Edinburgh BioQuarter – Gate 3, Edinburgh, EH16 4UX

More Details

Event Sponsors:

Media Partner: